Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
2020 · Arthritis Research & Therapy · 53 citations
https://doi.org/10.1186/s13075-020-02164-5
R
Raquel Campanilho‐Marques
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
716
Citations
16
h-index
21
i10-index
Raquel Campanilho‐Marques is an academic researcher from University of Lisbon. The author has contributed to research in topics: Inflammatory Myopathies and Dermatomyositis & Autoimmune and Inflammatory Disorders Research & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 16, co-authored 81 publications.
ORCID: 0000-0002-1894-8516Papers by this author
worksIdiopathic inflammatory myopathies: state of the art on clinical practice guidelines
2019 · RMD Open · 41 citations
https://doi.org/10.1136/rmdopen-2018-000784
Golimumab (anti-TNF monoclonal antibody): where we stand today
2020 · Human Vaccines & Immunotherapeutics · 23 citations
https://doi.org/10.1080/21645515.2020.1836919
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project
2024 · Arthritis & Rheumatology · 20 citations
https://doi.org/10.1002/art.43038
Reuma.pt/vasculitis – the Portuguese vasculitis registry
2020 · Orphanet Journal of Rare Diseases · 16 citations
https://doi.org/10.1186/s13023-020-01381-0
Clinically inactive disease in juvenile dermatomyositis – a proposed revision to the printo criteria
2014 · Pediatric Rheumatology · 0 citations
https://doi.org/10.1186/1546-0096-12-s1-p88
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat